USE OF EDG2 RECEPTOR IN AN ANIMAL MODEL OF HEART FAILURE

Details for Australian Patent Application No. 2003285314 (hide)

Owner AVENTIS PHARMA DEUTSCHLAND GMBH

Inventors KOSTENIS, Evi; WOHLFART, Paulus; HUBER, Jochen

Pub. Number AU-A-2003285314

PCT Number PCT/EP2003/0123

PCT Pub. Number WO2004/044003

Priority 02025161.7 11.11.02 EP

Filing date 5 November 2003

Wipo publication date 3 June 2004

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

C12N 015/86 Mutation or genetic engineering - Viral vectors

C12N 005/06 Undifferentiated human, animal or plant cells, e.g. cell lines -

A01K 067/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 02025161.7 11.11.02 EP

8 July 2004 Application Open to Public Inspection

  Published as AU-A-2003285314

21 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003285315-Aqueous, colloidal gas black suspension

2003285313-AQUEOUS CHROMOPHORE AND/OR EFFECT-PRODUCING COATING MATERIAL, AND USE OF THE SAME